Prognostic significance of serial magnetic resonance spectroscopies over the course of radiation therapy for patients with malignant glioma

Clinical and Investigative Medicine

Volumn 29, Issue 5, 2006, Pages 301-311

  Alexander, A ^a   Murtha, A ^a   Abdulkarim, B ^a   Mehta, V ^b   Wheatley, M ^b   Murray, B ^b   Riauka, T ^b   Hanson, J ^b   Fulton, D ^a   Urtasun, R ^a   McEwan, A ^b   Roa, Wilson ^a,c  

^a CROSS CANCER INSTITUTE   (Canada)

^b CROSS CANCER INSTITUTE   (United States)

^c Radiation Oncology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINE; LACTIC ACID; LIPID;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CANCER SURVIVAL; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; DISEASE COURSE; FEMALE; GLIOMA; HUMAN; KAPLAN MEIER METHOD; MALE; NEUTRON ACTIVATION ANALYSIS; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; PROGNOSIS;

BRAIN NEOPLASMS; FEMALE; GLIOMA; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; PROGNOSIS; SURVIVAL ANALYSIS;

EID: 33845347344     PISSN: 0147958X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. th edit. Philadelphia: Lippincot, Williams, and Walkins, 2001; 669-89, 2101.
2. Stupp R, Mason W, et al. Radiotherapy plus concomitant and adjuvant Temozolamide for Glioblastoma. NEJM, 2005; 352:987-96.
3. Constantinidis I. MRS and the practicing neurologist. Neurologist, 1998; 4:77-98.
4. Thomas MA, Ryner LN, Mehta MP, et al. Localized 2D J-resolved 1H-MR spectroscopy of human brain tumours in vivo. J Magn Reson Imaging, 1996; 6:453-9.
5. Chang L, Ernst T, Tornatore C, et al. Metabolite abnormalities in progressive multifocal leukoencephalopathy by proton MRS. Neurology, 1997; 48:836-45.
6. Rand SD, Prost R, Haughton C, et al. Accuracy of single voxel proton MR spectroscopy in distinguishing neoplastic from non-neoplastic lesons of the brain. AJNR, 1997; 18:1695-1704.
7. Oh D, Henning J, Erst T. Human brain tumours: assessment with magnetic resonance spectroscopy. Radiology, 1993; 186:745-52.
8. Chimm RJS, Wilkinson ID, Hall-Cragg MA, et al. Toxoplasmosis 8c Primary CNS Lymphoma in HIV infection: diagnosis with magnetic resonance spectroscopy. Radiology, 1995; 197:649-54.
9. Brenner RE, Munro PMG, Williams SCR, et al. The proton nuclear magnetic resonance spectrum in acute EAE: the significance of the change in Cho:Cr ratio. J Magn Reson Med, 1993; 29:737-45.
10. Maheswari SR, Fatterpekar GM, Castillo M, et al. Proton MR Spectroscopy of the brain. Semin Ultrasound CT MRI, 2000; 21:434-51.
11. Ross B, Blunt S. Magnetic resonance spectroscopy of the human brain: the anatomic record. New Anat, 2001; 265:54-84.
12. rd edn. Editors Stark, DD., Bradley, WG Jr. St Louis. Mosby. 1997; 181-214.
13. Bates TE, Stangwend M, Keelan J, et al. Inhibition of N-acetyl-aspartate production: Implications for 1H-MRS studies in vivo. Neuro Rep, 1996; 7:1937-1942.
14. Barbarella G, Ricc R, Pirini G, et al. In vivo single voxel 1H-Magnetic Resonance Spectroscopy of glial brain tumors: Correlation with tissue histology & In vitro MRS. Int J Oncol, 1998; 12: 461-68.
15. Rabinov JD, Lea PL, Barker FG, et al. In vivo 3T magnetic resonance spectroscopy in the distinction of recurrent glioma versus radiation effects: initial experience. Radiology, 2002; 225:871-9.
16. Tarnawski R, Sokol M, Pieniazek P, et al. 1H-MRS in vivo predicts the early treatment outcome of post-operative radiotherapy for malignant gliomas. Int J Radiat Oncol Biol Phys, 2002; 52:1271-6.
17. Rutkowski T, Tarnaski R, Sokol M, Maciejewski B. 1H-MRS of normal brain tissue before and after post-operative radiotherapy because of primary brain tumours. In J Radiat Oncol Biol Phys, 2003; 56:1383-9.
18. Poptani H, Gupta RK, Ray R, et al. Characterization of intracranial mass lesions with in vivo magnetic resonance spectroscopy. AJNR. 16:1593-1603.
19. Martin AJ, Liu H, Hall WA, et al. Preliminary assessment of turbo spectroscopy imaging for targeting in brain biopsy. AJNR, 2001; 22:959-68.
20. Hall WA, Martin A, Liu H, et al. Improving diagnostic yield in brain biopsy: coupling spectroscopy targeting with real time needle placement. J Magn Reson Imaging, 2001; 13:12-5.
21. Lichy MP, Bachent P, Henze M, et al. Monitoring individual response to brain tumour chemotherapy: proton MRS in a patient with recurrent glioma after stereotactic radiotherapy. Diagnostic Neuroradiology, 2004. 46:126-9.
22. Graves E, Nelson S, et al. Serial proton magnetic resonance imaging of recurrent malignant gliomas ater gamma knife radiosurgery. AJNR, 2001; 22:613-24.
23. Laprie A, Pirzkal A, et al. Longitudinal multi-voxel magnetic resonance spectroscopy study of pediatric diffuse brainstem gliomas treated with RT. Int J Radiat Oncol Biol Phys, 2005; 62: 20-31.
24. Kaminoga T, Shirac K. Radition induced brain metabolite changes in the acute and early delayed phase detected with quantitative proton magnetic resonance spectroscopy. J Comput Assist Tomogr, 2005; 29: 293-7.
25. Grande S, Luciani A, Viti V, et al. Radiation effects on soluble metabolites in cultured HeLa cells examined by 1H-MRS: Changes in concentration of glutathione & lipid catabolites induced by gamma rays and proton beams. Int J Cancer, 2001; 96 supp: 27-42.
26. Traber F, Block W, Schild HH. 1H-MRS of brain tumours in the course of radiation therapy: use of fast spectroscopic imaging and single-voxel spectroscopy for diagnosing recurrence. Rofo: Fortschritte auf dem Cebiete der Rongenstrahlen und der Nuknearmedizin, 2001; 174: 33-42.
27. Heestes MA, Kamman RL, Mooyaart EL, et al. Localized proton spectroscopy of inoperable brain gliomas: response to radiation therapy. J Neuro Oncology, 1997; 17: 27-35.
28. Isobe T, Matsumura A, Aryo I, et al. Changes in 1H-MRS in glioma patients before and after irradiation: the significance of quantitative analysis of choline-containing compounds. No Shinkei Geka - Neurologic Surgery, 2003; 21: 167-72.
29. Alexander A, Murtha A, Roa W, et al. Prospective characterization of serial magnetic resonance spectroscopy in patients with malignant glioma undergoing radiotherapy. Current Oncology, 2005; 12:18-22.
30. Curran W, Scott C, Horton J, et al. Recursive Partitioning Analysis of Prognostic Factors in Three Radiation Therapy Oncology Group Malignant Glioma Trials. Journal of the National Cancer Institute, 1993; 85:704-10.
31. Rack J, Heaskin D, Mikkelsen T, et al. Correlation between MRS & imaging guided histopathology, with special attention to radiation necrosis. Neurosurgery, 2002; 51:912-20.
32. Michaelis T, Mebollt KD, et al. Absolute concentrations of metabolites in the adult human brain in vivo: quantification of localized proton MR spectra. Neuroradiology, 1993; 187:219-22.
33. Simmons ML, Fondoza CG, et al. Immunohistochemical localization of N-acetyl-asparatate with monoclonal antibodies. Neuroscience, 1991; 45: 37-45.
34. Urenjak J, Williams S, Gadin D, et al. Proton nuclear magnetic resonance spectroscopy unambiguously identifies different neuronal cell types. J Neurosci, 1993; 13:981-9.
35. Dowling C, Bollen A, et al. Pre-operative proton magnetic resonance spectroscopy imaging of brain tumors: Correlation with histopathologic analysis of resection specimens. AJNR, 2001; 22: 604-12.
36. Esteve F, Rubin C, Grand S, et al. Transient metabolic changes observed with proton magnetic resoance spectroscopy in normal human brain after radiotherapy. Int J Radiat Oncol Biol Phys, 1998; 40: 279-86
37. Jagannathan, NR., et al. Evaluation of total choline from in vivo volume localized proton MR spectroscopy and its response to neoadjuvant chemotherapy in locally advanced breast cancer. Br J Cancer, 2001. 84: 1016-22.
38. Melsamy, S., et al. Neoadjuvant chemotherapy of locally advanced breast cancer: predicting response with in vivo MR spectroscopy- A pilot study at 4T. Radiology, 2004. 233(2): 424-31.
39. Schwartz, AJ., et al. Early in vivo detection of metabolic response: A pilot study of 1-H MR spectroscopy in extracranial lymphoma and germ cell tumours. Br J Radiology, 2002.79: 959-66.
40. Lazareff, JA., et al. Variation in post-treatment 1-H MRSI choline intensity in pediatric gliomas. J Neurooncology, 1999. 41: 291-8.